Literature DB >> 17181545

The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset.

J Michael Andresen1, Javier Gayán, Luc Djoussé, Simone Roberts, Denise Brocklebank, Stacey S Cherny, Lon R Cardon, James F Gusella, Marcy E MacDonald, Richard H Myers, David E Housman, Nancy S Wexler.   

Abstract

Age of onset for Huntington's disease (HD) varies inversely with the length of the disease-causing CAG repeat expansion in the HD gene. A simple exponential regression model yielded adjusted R-squared values of 0.728 in a large set of Venezuelan kindreds and 0.642 in a North American, European, and Australian sample (the HD MAPS cohort). We present evidence that a two-segment exponential regression curve provides a significantly better fit than the simple exponential regression. A plot of natural log-transformed age of onset against CAG repeat length reveals this segmental relationship. This two-segment exponential regression on age of onset data increases the adjusted R-squared values by 0.012 in the Venezuelan kindreds and by 0.035 in the HD MAPS cohort. Although the amount of additional variance explained by the segmental regression approach is modest, the two slopes of the two-segment regression are significantly different from each other in both the Venezuelan kindreds [F(2, 439) = 11.13, P= 2 x 10(-5)] and in the HD MAPS cohort [F(2, 688) = 38.27, P= 2 x 10(-16)]. In both populations, the influence of each CAG repeat on age of onset appears to be stronger in the adult-onset range of CAG repeats than in the juvenile-onset range.

Entities:  

Mesh:

Year:  2006        PMID: 17181545     DOI: 10.1111/j.1469-1809.2006.00335.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  46 in total

1.  A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.

Authors:  Damian M Cummings; Yasaman Alaghband; Miriam A Hickey; Prasad R Joshi; S Candice Hong; Chunni Zhu; Timothy K Ando; Véronique M André; Carlos Cepeda; Joseph B Watson; Michael S Levine
Journal:  J Neurophysiol       Date:  2011-11-09       Impact factor: 2.714

2.  Inhibition of Huntingtin Exon-1 Aggregation by the Molecular Tweezer CLR01.

Authors:  Tobias Vöpel; Kenny Bravo-Rodriguez; Sumit Mittal; Shivang Vachharajani; David Gnutt; Abhishek Sharma; Anne Steinhof; Oluwaseun Fatoba; Gisa Ellrichmann; Michael Nshanian; Christian Heid; Joseph A Loo; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Erich E Wanker; Simon Ebbinghaus; Elsa Sanchez-Garcia
Journal:  J Am Chem Soc       Date:  2017-04-13       Impact factor: 15.419

Review 3.  Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Nathanael Hevelone; Steven M Hersch
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

4.  Structure and topology of the huntingtin 1-17 membrane anchor by a combined solution and solid-state NMR approach.

Authors:  Matthias Michalek; Evgeniy S Salnikov; Burkhard Bechinger
Journal:  Biophys J       Date:  2013-08-06       Impact factor: 4.033

Review 5.  CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.

Authors:  Douglas R Langbehn; Michael R Hayden; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

6.  Decorrelating Kinetic and Relaxation Parameters in Exchange Saturation Transfer NMR: A Case Study of N-Terminal Huntingtin Peptides Binding to Unilamellar Lipid Vesicles.

Authors:  Alberto Ceccon; G Marius Clore; Vitali Tugarinov
Journal:  J Phys Chem B       Date:  2018-09-12       Impact factor: 2.991

7.  Interaction of Huntingtin Exon-1 Peptides with Lipid-Based Micellar Nanoparticles Probed by Solution NMR and Q-Band Pulsed EPR.

Authors:  Alberto Ceccon; Thomas Schmidt; Vitali Tugarinov; Samuel A Kotler; Charles D Schwieters; G Marius Clore
Journal:  J Am Chem Soc       Date:  2018-05-14       Impact factor: 15.419

8.  Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease.

Authors:  Catherine F Higham; Darren G Monckton
Journal:  J R Soc Interface       Date:  2013-09-18       Impact factor: 4.118

9.  Protein Interactions with Nanoparticle Surfaces: Highlighting Solution NMR Techniques.

Authors:  Y Randika Perera; Rebecca A Hill; Nicholas C Fitzkee
Journal:  Isr J Chem       Date:  2019-09-19       Impact factor: 3.333

10.  Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases.

Authors:  Keizo Sugaya; Shiro Matsubara
Journal:  Mol Neurodegener       Date:  2009-07-15       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.